BCR-ABL testing in the evaluation of neutrophilia

Am J Hematol. 2024 Aug;99(8):1651-1654. doi: 10.1002/ajh.27373. Epub 2024 May 17.

Authors

Caleb J Smith¹, Gordon J Ruan¹, Lindsey Ann Kluck², Mackenzie Maberry³, Ronald S Go¹

Affiliations

¹ Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Hematology/Oncology, University of Massachusetts Medical Center, Worcester, Massachusetts, USA.
³ Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 38760992
DOI: 10.1002/ajh.27373

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Female
Fusion Proteins, bcr-abl* / genetics
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
Male
Middle Aged
Neutrophils* / pathology

Substances

Fusion Proteins, bcr-abl